By combining bioidentical hormone therapy with GLP-1 weight loss peptides and a dedicated exercise routine, the patient experienced transformative results
Desde el 1 de octubre, Ozempic (semaglutida inyectable) , el tratamiento anlogo del GLP-1 de prescripcin mdica de Novo Nordisk, indicado para adultos con diabetes tipo 2 que no han logrado un control glucmico adecuado y como complemento de la dieta y el ejercicio, vuelve a estar disponible con normalidad en las farmacias espaolas
Muscle mass drives resting metabolic rate, supports joint health, improves insulin sensitivity, and becomes increasingly important for long-term weight maintenance after GLP-1 treatment ends
and it may increase the risk of hypoglycaemia when used with insulin or sulfonylureas
Most breast changes caused by GLP-1 use and weight loss are usually benign however you should seek assessment if you notice: A new lump or area of thickening One breast changing more than the other Skin dimpling, redness or puckering Nipple inversion or discharge Persistent pain in an area Even when changes are likely to be weight-related, imaging (ultrasound, mammography or MRI in selected cases) can provide clarity and peace of mind and also enables a new post weight-loss baseline to be established
A March 2026 study from Washington University School of Medicine, published in BMJ Medicine, found that stopping GLP-1 medications can rapidly erase those cardiac benefits
.webp)
